Page 14 - ICCS 2011 Program Web

This is a SEO version of ICCS 2011 Program Web. Click here to view full version

« Previous Page Table of Contents Next Page »
12
ICCS 2011
EXHIBIT DIRECTORY
Alexion Pharmaceuticals, Inc.
is a
global biotechnology company committed
to meeting the needs of patients living
with severe, life-threatening and ultra-
rare diseases. Alexion is engaged
in the discovery, development and
commercialization of therapeutic products
aimed at treating patients with a wide
array of severe disease states, including
hematologic and kidney diseases, transplant,
other infammatory disorders, and cancer.
Amnis Corporation
introduces the
revolutionary FlowSight, a 12 channel fow
cytometer that images every cell and is
priced for every lab. For more demanding
requirements, Amnis’ ImageStreamX
imaging fow cytometer delivers the ultimate
in image quality and the broadest range of
image-based applications, including co-
localization, nuclear translocations, shape
change/morphology, and more.
Bangs Laboratories
manufactures a range
of innovative standardization and analysis
solutions for clinical and research fow
cytometry labs. Our microsphere-based
products include Quantum™ systems for
cellular expression analysis, QuantumPlex™
for assay development, and numerous
reference and QC standards, now also
including several dedicated products for the
violet laser
Becton, Dickinson and Company
, is one
of the world’s leading businesses focused
on bringing innovative tools to life science
researchers and clinicians. Its product lines
include: fow cytometers, cell imaging
systems, monoclonal antibodies, research
reagents, diagnostic assays, and tools to help
grow tissue and cells.
Beckman Coulter
provides a
comprehensive line of fow cytometry
solutions that lead the charge against
life’s most challenging diseases. Our
instruments, sample preparation systems
and family of antibodies, including many for
Immunophenotyping, offer an unparalleled
continuum of cellular testing – while
building productivity, boosting throughput
and bolstering positive clinical outcomes.